InvestorsHub Logo
Followers 138
Posts 22891
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Thursday, 11/11/2021 8:21:17 AM

Thursday, November 11, 2021 8:21:17 AM

Post# of 255
GREAT news this morning 3 batches at date I say 200 liter batch size.

That is EXCELLENT NEWS. That should be enough material to treat 10s of thousands if not hundreds of thousands of men and women with Parkinson’s’ disease.

Ready for commercialization.

“Today’s announcement is the culmination of several months of effort by the Sio and Oxford BioMedica teams focused on the development of a reliable, suspension-based manufacturing process to enable scale-up of production and advancement of the AXO-Lenti-PD program,” said Pavan Cheruvu, M.D., Chief Executive Officer of Sio Gene Therapies. “With the successful manufacture of three batches, all of which achieved the target titer and have completed fill and finish, we now have a process that has generated sufficient clinical trial material for future clinical development. We believe these data, coupled with scientific advice from the MHRA, help clarify the path forward and collectively represent an inflection point for the AXO-Lenti-PD program.”

https://finance.yahoo.com/news/sio-gene-therapies-announces-successful-120000897.html

Good luck and GOD bless,

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.